Adaptimmune Therapeutics plc (NASDAQ:ADAP) Q2 2024 Earnings Call Transcript August 12, 2024
Operator: Good day and welcome to the Adaptimmune Second Quarter 2024 Conference Call. All participants will be in a listen-only mode. [Operator Instructions] After today’s presentation, there will be an opportunity to ask questions. [Operator Instructions] Please note this event is being recorded. I would now like to turn the conference over to Dan Od-Cohen, Investor Relations. Please go ahead.
Dan...
